You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
|
|---|---|
| Published in |
BMC Cancer, May 2010
|
| DOI | 10.1186/1471-2407-10-229 |
| Pubmed ID | |
| Authors |
Rosa S Schneiderman, Esther Shmueli, Eilon D Kirson, Yoram Palti |
| Abstract |
Exposure of cancer cells to chemotherapeutic agents may result in reduced sensitivity to structurally unrelated agents, a phenomenon known as multidrug resistance, MDR. The purpose of this study is to investigate cell growth inhibition of wild type and the corresponding MDR cells by Tumor Treating Fields--TTFields, a new cancer treatment modality that is free of systemic toxicity. The TTFields were applied alone and in combination with paclitaxel and doxorubicin. |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Israel | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 91 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 25% |
| Student > Ph. D. Student | 18 | 19% |
| Student > Bachelor | 8 | 9% |
| Other | 8 | 9% |
| Student > Master | 7 | 8% |
| Other | 13 | 14% |
| Unknown | 16 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 26% |
| Agricultural and Biological Sciences | 12 | 13% |
| Biochemistry, Genetics and Molecular Biology | 11 | 12% |
| Engineering | 9 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Other | 16 | 17% |
| Unknown | 16 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#4,939,383
of 23,943,619 outputs
Outputs from BMC Cancer
#1,249
of 8,521 outputs
Outputs of similar age
#20,162
of 97,579 outputs
Outputs of similar age from BMC Cancer
#11
of 64 outputs
Altmetric has tracked 23,943,619 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,521 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,579 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.